根据《公司法》《上市公司独立董事规则》《深圳证券交易所上市公司自律 监管指引第 1 号-主板上市公司规范运作》等法律、法规和规范性文件以及金陵 华软科技股份有限公司的《公司章程》等有关规定，我们作为金陵华软科技股份 有限公司(以下简称"公司")的独立董事，在经对相关资料文件充分了解且核实 后，就公司第六届董事会第十五次会议审议的聘任公司财务总监相关事项进行了 解,现基于独立判断的立场,本着独立性、客观性、公正性的原则发表独立意见如 下: 经认真审阅陈涛先生个人履历、教育背景、工作经历等相关资料，我们认为： 1、本次公司财务总监的提名、审议、表决、聘任程序符合《公司法》和 《公司章程》等有关规定，程序合法有效，不存在损害公司及其他股东利益的 情形。 2、经核查，陈涛先生具备相关法律法规和《公司章程》规定的任职条件， 未发现有《公司法》规定不得担任公司高级管理人员的情形。陈涛先生拥有相 关专业知识和工作经验，具备担任高级管理人员的资格和能力，具备与其行使 职权相适应的任职能力。 金陵华软科技股份有限公司 独立董事关于第六届董事会第十五次会议相关事项的 独立意见 王新安 李永军 刘彦山 签字日期： 2023 年 8 ...

证券代码：002453 证券简称：华软科技 公告编号：2023-072 金陵华软科技股份有限公司 关于公司诉讼进展暨收到民事判决书的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或者重大遗漏。 特别提示： 1.案件所处的诉讼阶段：二审已判决 2.上市公司所处的当事人地位：上诉人（一审原告） 3.涉案金额：1,186.5 万元 4.对上市公司损益产生的影响：本次涉诉的案件已取得二审判决， 处于法院判决的履行期限内，后续案件的执行结果存在一定的不确定 性。本次案件预计不会对公司生产经营及利润产生不利影响。基于谨 慎性原则，公司已根据企业会计准则对本次诉讼涉及的应收账款计提 了相关坏账准备，公司后续将根据执行情况进行相应会计处理，最终 会计处理及影响金额以会计师事务所审计确认后的结果为准。 金陵华软科技股份有限公司（以下简称"公司"）于近日收到江 苏省苏州市中级人民法院（2023）苏 05 民终 7474 号《民事判决书》。 现将相关诉讼案件进展情况公告如下： 一、 本次诉讼事项的基本情况 金陵华软科技股份有限公司（以下简称"公司"）于 2022 年 2 月 22 日就与苏州正 ...

Financial Performance - The company reported a revenue of 500 million RMB for the first half of 2023, representing a 15% increase compared to the same period last year[25]. - The company has set a revenue guidance of 1.2 billion RMB for the full year 2023, indicating a projected growth of 10%[25]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion in the first half of 2023, representing a 20% year-over-year growth[141]. - The company provided guidance for the next quarter, expecting revenue to grow by 10% to 1.65 billion[141]. - The company achieved a net profit of 80 million RMB, with a profit margin of 16%, an increase from 14% in the same period last year[198]. - The company has set a performance guidance of 1 billion RMB in revenue for the full year 2023, reflecting a growth target of 20%[198]. User Engagement - User data showed a growth of 20% in active users, reaching 1.2 million by the end of June 2023[25]. - User data showed a 15% increase in active users, reaching 3 million by the end of Q2 2023[141]. - User data showed an increase in active users by 25% to 1.2 million, indicating strong customer engagement and retention[198]. Product Development - New product launches in the first half included three innovative chemical products, contributing to 30% of total sales[25]. - New product launches are anticipated to contribute an additional 200 million in revenue by Q3 2023[141]. - New product development includes the launch of an AI-driven software solution, expected to generate an additional 50 million RMB in revenue by Q4 2023[198]. - The company has allocated 10% of its annual budget for R&D, focusing on enhancing existing technologies and developing new applications[198]. Market Expansion - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by the end of 2024[25]. - Market expansion plans include entering two new international markets by the end of 2023, projected to increase market share by 5%[141]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% increase in market share by the end of 2024[198]. Research and Development - Research and development expenses increased by 18%, totaling 50 million RMB, focusing on advanced chemical technologies[25]. - The company is investing 50 million in R&D for new technologies aimed at enhancing product features[141]. - The company has allocated 10% of its annual budget for R&D, focusing on enhancing existing technologies and developing new applications[198]. Strategic Acquisitions - The company plans to pursue strategic acquisitions to enhance its product portfolio, with a budget of 200 million RMB allocated for potential targets[25]. - The company is considering strategic acquisitions to bolster its technology portfolio, with a budget of 100 million allocated for potential deals[141]. - Jinling Huasoft is exploring potential acquisitions to bolster its technology portfolio, with a target of completing at least one acquisition by mid-2024[198]. Cost Management - The gross profit margin improved to 35%, up from 30% in the previous year, due to cost optimization strategies[25]. - The company reported a net profit margin of 25%, up from 22% in the previous year[141]. - The gross margin improved to 40%, up from 38% in the previous year, due to cost optimization strategies[198]. - Operating expenses increased by 5% due to higher marketing costs associated with new product launches[141]. - The company plans to enhance its supply chain efficiency, aiming for a 10% reduction in costs by Q4 2023[141]. Risk Management - The company has identified potential risks related to supply chain disruptions and is implementing measures to mitigate these risks[25]. Accounting Practices - The group prepares financial statements based on the actual transactions and events in accordance with accounting standards and guidelines[31]. - The group has established specific accounting policies and estimates for bad debt provisions, inventory valuation, fixed asset depreciation, and revenue recognition[32]. - The group recognizes direct costs incurred during business combinations in the current period's profit and loss[37]. - For non-similar control business combinations, the acquisition cost includes the fair value of assets paid for control, liabilities assumed, and issued equity securities[38]. - The group includes the operating results and cash flows of newly acquired subsidiaries in the consolidated financial statements from the acquisition date[41]. - The group has implemented an incentive plan, granting 8,053,000 stock options at an exercise price of 19.98 CNY per share to 113 individuals[47]. - The group adheres to various environmental protection laws and regulations during its production operations[48]. - The group has established an emergency organization and conducts biannual drills to enhance employee safety awareness[51]. - The group measures impairment losses for financial assets based on expected credit losses over the next 12 months or the entire duration of the asset[55]. - The group assesses the credit risk of financial instruments at initial recognition and measures impairment losses accordingly[59]. - The company measures long-term receivables with significant financing components based on expected credit losses over the life of the asset[60]. - The company recognizes impairment losses for financial assets based on expected credit loss methods, either general or simplified, depending on the credit risk increase since initial recognition[82]. - The company classifies non-current assets held for sale if they meet specific criteria, including the ability to sell within one year and having a firm purchase commitment[68]. - The company does not depreciate or amortize non-current assets held for sale, and interest and other expenses related to liabilities in the disposal group continue to be recognized[69]. - The company uses fair value measurement techniques for financial instruments, prioritizing observable inputs when available[79]. - The company recognizes expected credit losses for other debt investments based on whether credit risk has significantly increased since initial recognition[88]. - The company applies a perpetual inventory system for inventory management, measuring inventory at the lower of cost or net realizable value[92]. - The company accounts for long-term equity investments using the equity method for investments with significant influence or joint control[101]. - The company recognizes contract assets for rights to receive consideration that are conditional on the company's performance[93]. - The company measures impairment losses for long-term receivables based on expected credit losses over the life of the asset if not using simplified approaches[88]. - The company confirmed that the carrying value of long-term equity investments is limited to zero when recognizing the net loss of investees[103]. - The company adopts the cost model for subsequent measurement of investment properties, with depreciation rates for buildings ranging from 2.375% to 9.50% depending on the asset type[112]. - The estimated useful life of investment properties is set at 40 years with a net residual value rate of 5%[133]. - The company recognizes investment losses when the fair value of remaining equity investments is less than their carrying amount upon losing joint control or significant influence[106]. - The company capitalizes foreign exchange differences on specialized borrowings during the capitalization period[122]. - The company adjusts capital reserves for the difference between newly acquired long-term equity investments and the net asset share of subsidiaries from the purchase date[128]. - The company applies the equity method for long-term equity investments, with adjustments made to the initial investment cost based on the fair value of identifiable net assets[126]. - The company recognizes other comprehensive income proportionally when disposing of equity investments under the equity method[129]. - The company conducts annual reviews of fixed asset useful lives, expected net residual values, and depreciation methods[114]. - The company will transfer the carrying amount of investment properties to profit or loss upon disposal or permanent withdrawal from use[110]. - The company reported that the capitalization of borrowing costs ceases when the asset meets the conditions for capitalization and is ready for use or sale[166]. - The company will suspend the capitalization of borrowing costs if there is an abnormal interruption in the construction or production of capitalizable assets lasting more than 3 months[166]. - The company conducts impairment testing for intangible assets with finite useful lives and reviews their useful lives and amortization methods at the end of the period[169]. - The company classifies its internal research and development expenditures into research phase and development phase expenditures[171]. - Expenditures in the development phase are recognized as intangible assets only if they meet specific criteria, including technical feasibility and the ability to generate economic benefits[172]. - The company’s cash and cash equivalents include cash on hand, deposits available for payment, and short-term investments with low risk of value change[173]. - The company recognizes foreign currency transactions at the spot exchange rate on the transaction date[174]. - The company applies the spot exchange rate at the balance sheet date for foreign currency monetary items, with exchange differences recognized in profit or loss[175]. - The company measures financial assets at fair value upon initial recognition, with transaction costs accounted for differently based on the asset classification[184]. - The company performs annual impairment testing for goodwill and intangible assets with indefinite useful lives, regardless of whether there are impairment indicators[190].

证券代码：002453 证券简称：华软科技 公告编号：2023-071 金陵华软科技股份有限公司 关于公司内部股权转让的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 金陵华软科技股份有限公司（以下简称"公司"）于 2023 年 8 月 14 日召开第六届董事会第十四次会议，审议通过了《关于公司内 部股权转让的议案》。现将相关情况公告如下： 一、本次内部股权转让方案 为进一步整合业务板块，提升管理效率，公司全资子公司苏州 天马恒建健康科技有限公司（以下简称"天马恒建"）拟将其持有 的华软金信科技（苏州）有限公司（以下简称"华软金信"）100% 股权以 1 元转让给公司。上述股权转让完成后，公司将直接持有华 软金信 100%股权，华软金信将由公司全资孙公司变为全资子公司。 同时，公司拟将直接持有的全资子公司南通市纳百园化工有限 公司（以下简称"纳百园化工"）100%股权和控股子公司山东天安 化工股份有限公司（以下简称"天安化工"）90.71%股权分别以 6,257.52 万元、14,481.46 万元转让给华软金信，并拟将持有的控 股子公司福建省力菲克药业 ...

| | 北京奥得赛化学有 | 控股子公司 | 其他应收款 | 14,682.11 | 266.86 | 273.11 | 2,000.00 | 13,222.08 资金拆借 | 非经营性往来 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 限公司 | | | | | | | | | | | 苏州天马恒建健康 科技有限公司 | 控股子公司 | 其他应收款 | 810.54 | 20.00 | | | 830.54 资金拆借 | 非经营性往来 | | | 华软金信科技（苏 州）有限公司 | 控股子公司 | 其他应收款 | 306.24 | 2,351.77 | | 2,002.16 | 655.85 资金拆借 | 非经营性往来 | | | 南通市纳百园化工 有限公司 | 控股子公司 | 其他应收款 | 9,001.83 | 5,217.35 | 213.96 | 13,168.15 | 1,264.99 资金拆借 | 非经营性往来 | | | 深圳金信汇通商业 保理有限公司 | 控股子公司 | 其他应收款 | 3,469.85 ...

证券代码：002453 证券简称：华软科技 公告编号：2023-068 金陵华软科技股份有限公司 第六届董事会第十四次会议决议的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 金陵华软科技股份有限公司（以下简称"公司"）第六届董事会 第十四次会议（以下简称"会议"）通知于 2023 年 8 月 4 日以传真、 专人送达、邮件等方式发出，会议于 2023 年 8 月 14 日在苏州苏站路 1588 号世界贸易中心 B 座 21 层公司会议室以现场和通讯相结合的方 式召开。会议应到董事 7 名，实到董事 7 名。公司部分监事及高管人 员列席了会议。会议由翟辉董事长主持。本次会议的召集、召开以及 参与表决董事人数符合《公司法》《公司章程》等有关规定。经参加会 议董事认真审议并经记名投票方式表决，通过以下决议： 一、会议以 7 票同意，0 票反对，0 票弃权，审议并通过了《2023 年半年度报告及摘要》 董事会经审核后认为：公司 2023 年半年度报告及其摘要的编制 和审议程序符合《公司法》《深圳证券交易所股票上市规则》等法律 法规，《公司章程》等规章制度的要求；报 ...

根据《公司法》《上市公司独立董事规则》《深圳证券交易所上市公司自律 监管指引第 1 号-主板上市公司规范运作》等法律、法规和规范性文件以及金陵 华软科技股份有限公司的《公司章程》等有关规定，我们作为金陵华软科技股份 有限公司(以下简称"公司")的独立董事，在经对相关资料文件充分了解且核实 后，现就公司第六届董事会第十四次会议审议的 2023 年半年度报告及相关事项 进行了解,基于独立判断的立场,本着独立性、客观性、公正性的原则发表独立意 见如下: 一、关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说 明和独立意见 根据中国证监会、深圳证券交易所及公司治理规则等相关规定，我们作为独 立董事，本着实事求是的态度，对公司控股股东及其他关联方占用资金的情况和 公司对外担保的情况进行了认真检查，现就相关情况发表独立意见如下： 1、报告期内对外担保情况： 金陵华软科技股份有限公司 独立董事关于第六届董事会第十四次会议相关事项的 独立意见 2022 年度，公司完成出售重大资产倍升互联（北京）科技有限公司（以下简 称"倍升互联"）股权事宜，出售前存在公司对倍升互联及其下属子公司担保的 情形，根据约定，出售后相关 ...

证券代码：002453 证券简称：华软科技 公告编号：2023-069 金陵华软科技股份有限公司 第六届监事会第十三次会议决议的公告 本公司及监事会全体成员保证公告内容真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 金陵华软科技股份有限公司（以下简称"公司"）第六届监事会 第十三次会议（以下简称"会议"）通知于 2023 年 8 月 4 日向全体监 事发出，会议于 2023 年 8 月 14 日在苏州苏站路 1588 号世界贸易中 心 B 座 21 层公司会议室以现场和通讯相结合的方式召开。会议应到 监事 3 名，实到监事 3 名。会议由监事会主席李占童主持。本次会议 的召集、召开以及参与表决监事人数符合《公司法》《公司章程》等有 关规定。经参加会议监事认真审议并经记名投票方式表决，通过以下 决议： 一、会议以 3 票同意，0 票反对，0 票弃权，审议并通过了 《2023 年半年度报告及摘要》 具体内容详见公司于 2023 年 8 月 15 日披露在《证券时报》《中 国证券报》《上海证券报》及巨潮资讯网站（www.cninfo.com.cn）的 《2023 年半年度报告及摘要》。 二、会议以 3 ...

股票代码：002453 股票简称：华软科技 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及 人员姓名 线上参与公司华软科技 2022 年度报告网上说明会的投资 者 时间 2023 年 05 月 16 日（星期二）下午 15:00-17:00 地点 "华软科技投资者关系"微信小程序 上市公司接待人 员姓名 董事长：翟辉先生 独立董事 ：王新安先生 董事兼常务副总裁：张旻逸先生 副总裁兼财务总监：罗琳女士 副总裁兼董事会秘书：吕博女士 投资者关系活动 主要内容介绍 1、问：净利润连续两年均为负值，请问什么原因？有何 措施改善？ 答：您好！ 公司净利润连续亏损主要原因为控股子公司 奥得赛化学未能完成 2021-2022 年度业绩承诺，根据《企 业会计准则第 8 号-资产减值》及相关会计政策规定，公 司 2021-2022 年度共计提商誉减值准备 62,875 万元。 未来，公司将整合资源，优化精细化工业务。充分发挥公 司在造纸化学品和医药中间体领域的优势，一方面巩固现 有市场份额，另一方面加大毛利 ...

金陵华软科技股份有限公司 2023 年第一季度报告 证券代码：002453 证券简称：华软科技 公告编号：2023-043 金陵华软科技股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 □是 否 1 金陵华软科技股份有限公司 2023 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经审计 | | 本报告期 | 上年同期 | 本报告期比上年同期增减（%） | | --- | --- | --- | --- | | 营业收入（元） | 129,417,408.77 | 923,455,910.15 | -85.99% | | 归属于上市公司股东的净利润 | -21 ...